Exploring Accessible Beauty for Individuals With Upper Extremity Deficits
NCT05945784 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57
Last updated 2023-12-06
Summary
The purpose of this study is to investigate the accessibility of beauty products for individuals with upper extremity disabilities. By examining various factors such as packaging design, product applicators, and ease of use, this research aims to identify barriers faced by individuals with upper extremity disabilities or visual deficits when using beauty products. The study seeks to provide insights and recommendations for improving the accessibility of beauty products, ultimately promoting inclusivity and enhancing the overall beauty experience for individuals with disabilities.
Conditions
- Stroke, Ischemic
- Stroke Hemorrhagic
- Stroke (CVA) or TIA
- Stroke, Acute
- Traumatic Brain Injury
- SCI - Spinal Cord Injury
- Ehlers-Danlos Syndromes (EDS)
- Lupus Erythematosus
- Guillain-Barre Syndrome
- Multiple Sclerosis
- Myasthenia Gravis
- Amyotrophic Lateral Sclerosis
- Graves Disease
- Muscular Dystrophies
Interventions
- OTHER
-
Use of Rare Beauty makeup products
Participants will be provided with a selection of beauty products items including foundation, concealer, blush, highlighter, and lipstick, specifically chosen for their potential accessibility features. They will have a specified trial period during which they can use the products as part of their regular beauty routines.
Sponsors & Collaborators
-
Casa Colina Hospital and Centers for Healthcare
lead OTHER
Principal Investigators
-
Emily Rosario, PhD · Casa Colina Hospital and Centers for Healthcare
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-07-21
- Primary Completion
- 2023-09-15
- Completion
- 2023-09-29
Countries
- United States
Study Locations
More Related Trials
-
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination
NCT04247074 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Four Injectable Neuromodulators in the Glabella Area Glabella Area
NCT05167864 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Evaluation of Erbium Treatment
NCT00766376 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines
NCT04259086 ·Status: COMPLETED ·Phase: PHASE2
-
Perioral Rejuvenation and Upper Lip Enhancement
NCT03273543 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of the EndyMed Pro System Using RF Micro-needles Fractional Skin Remodeling
NCT02368626 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Skin Quality Improvement
NCT03097835 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of Antria Cell Preparation Process to Enhance Facial Fat Grafting With Adipose Derived Stem Cells
NCT01828723 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products
NCT06783621 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Moderate to Severe Lateral Canthal Lines
NCT04249687 ·Status: COMPLETED ·Phase: PHASE3
-
Injectable Filler for Cheek Flattening
NCT01225354 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Performance of Princess® FILLER for the Treatment of Facial Lipoatrophy, Asymmetry or Scars
NCT03050723 ·Status: COMPLETED ·Phase: NA
-
Treatment of the Face and Neck With Lower Ulthera System Energy Settings
NCT01713998 ·Status: COMPLETED ·Phase: NA
-
Combination Facial Aesthetic Treatment in Millennials
NCT04755595 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Efficacy of Skin Rejuvenation Therapy in Combination With Neurotoxin and Full Facial Filler Treatments
NCT02551562 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Lateral Canthal Lines
NCT04143854 ·Status: COMPLETED ·Phase: PHASE2
-
Assess the Impact of Lip Rejuvenation on Projected First Impressions and Mood Perceptions
NCT03241862 ·Status: COMPLETED ·Phase: NA
-
MT10109L in the Treatment of Lateral Canthal Lines
NCT03785145 ·Status: COMPLETED ·Phase: PHASE3
-
Upper Facial Remodeling With Perlane-L and Dysport
NCT01354743 ·Status: COMPLETED ·Phase: PHASE4
-
A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Voluma
NCT06565988 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Ulthera System for the Treatment of the Decolletage
NCT01713686 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Ulthera® System for Treatment of the Face and Neck
NCT01713907 ·Status: TERMINATED ·Phase: NA
-
MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)
NCT04157686 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility Study: Histological Characterization After Treatment With the Ulthera® System
NCT01713569 ·Status: TERMINATED ·Phase: NA
-
2910 nm Erbium-Doped Fluoride Fiber Glass Laser for the Treatment of Advanced Perioral Lines and Wrinkles
NCT07222397 ·Status: RECRUITING ·Phase: NA